<div id="readability-page-1"><p>Maximus, Inc. (NYSE:MMS - Get Free Report) CFO David Mutryn purchased 1,000 shares of the stock in a transaction that occurred on Monday, February 9th. The stock was acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This represents a 2.56% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.</p><h2>Maximus Price Performance</h2><p>Shares of MMS traded up $0.01 during midday trading on Monday, hitting $75.09. 1,168,871 shares of the company traded hands, compared to its average volume of 674,064. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 11.43 and a beta of 0.56. The firm has a 50 day moving average of $90.07 and a 200-day moving average of $86.58. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $100.00. </p><p>Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the firm posted $1.61 earnings per share. Maximus's revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS.  On average, analysts forecast that  Maximus, Inc. will post 6.15 EPS for the current fiscal year. </p><h2>Maximus Increases Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a $0.33 dividend. This is a boost from Maximus's previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus's dividend payout ratio  is currently 18.26%. </p><h2>Analyst Ratings Changes</h2><p>MMS has been the topic of a number of research reports. Zacks Research raised shares of Maximus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, December 30th. Wall Street Zen cut Maximus from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday. Finally, Weiss Ratings  reaffirmed a &#34;buy (b-)&#34; rating on shares of Maximus in a research note on Monday, December 29th. One equities research analyst  has rated the stock with a Strong Buy rating and one  has issued  a Buy rating to the company. According to data from MarketBeat.com, the stock  has an average rating of &#34;Strong Buy&#34;.</p><p><b>Read Our Latest Analysis on Maximus</b></p><h2>Institutional Inflows and Outflows</h2><p>Hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its holdings in shares of  Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after purchasing an additional 36,989 shares during the period.  Geode Capital Management LLC increased its holdings in  Maximus by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider's stock worth $127,952,000 after buying an additional 5,130 shares during the period.  Boston Partners raised its position in  Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after buying an additional 308,892 shares during the last quarter.  Reinhart Partners LLC. lifted its stake in  Maximus by 0.8% during the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock valued at $84,206,000 after acquiring an additional 7,722 shares during the period.  Finally, Stephens Investment Management Group LLC boosted its holdings in shares of  Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock valued at $65,873,000 after acquiring an additional 237,097 shares during the last quarter. Institutional investors and hedge funds own  97.21% of the company's stock. </p><h2>Maximus Company Profile</h2> (Get Free Report)<p>Maximus, Inc <span>NYSE: MMS<span></span></span> is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.</p><h2>Read More</h2><ul><li>Five stocks we like better than Maximus</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>Your Bank Account Is No Longer Safe</li><li>Buy this Gold Stock Before May 2026</li><li>The day the gold market broke</li><li>What a Former CIA Agent Knows About the Coming Collapse</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Maximus Right Now?</h2><p>Before you consider Maximus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p><p>While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Maximus CFO David Mutryn acquired 1,000 shares of the company's stock at $75.62 per share, totaling $75,620. This purchase increased his ownership by 2.56%, bringing his total shares to 40,037, valued at approximately $3.03 million. The stock recently traded at $75.09, with a market cap of $4.10 billion. Maximus reported earnings of $1.85 per share, exceeding estimates, and announced a dividend increase to $0.33 per share, payable on March 2nd. Analysts have mixed ratings on the stock, with an average rating of "Strong Buy."</p>

Maximus (NYSE:MMS) CFO Acquires $75,620.00 in Stock